C12N 2710/20063
By chemical treatment
Official title: by chemical treatment
C12N2710/20063 (By chemical treatment) appears on 4 US grants and 13 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 13
- Assignees
- 3
- Inventors
- 5
- Latest grant
- 20 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 3 |
| 2020 | 1 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 3 |
| 2023 | 1 | 2 |
| 2024 | 0 | 2 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Compositions, methods and uses for thermally stable multi-targeted antigens20 May 2025US 12,303,602 B2The Regents of the University of Colorado, a body corporate
- Compositions, methods and uses for thermally stable multi-targeted antigens7 Nov 2023US 11,806,432 B2The Regents of the University of Colorado, a body corporate
- Compositions, methods and uses for thermally stable multi-targeted antigens15 Mar 2022US 11,273,127 B2The Regents of the University of Colorado, a body corporate
- Method for preventing or treating viral infection and tumor21 Jul 2020US 10,716,769 B2Guangzhou Jtreat Biosci. Ltd.
- Compositions, methods and uses for thermally stable multi-targeted antigens11 Jul 2024US 2024/0226015 A9The Regents of the University of Colorado, a body corporate
- Compositions, methods and uses for thermally stable multi-targeted antigens25 Apr 2024US 2024/0130973 A1The Regents of the University of Colorado, a body corporate
- Compositions, methods and uses for thermally stable human papillomavirus formulations9 Nov 2023US 2023/0355739 A1The Regents of the University of Colorado, a body corporate
- Compositions, methods and uses for thermally stable human papillomavirus formulations21 Sep 2023US 2023/0293662 A1The Regents of the University of Colorado, a body corporate
- Compositions, methods and uses for thermally stable human papillomavirus formulations24 Nov 2022US 2022/0370592 A1The Regents of the University of Colorado, a body corporate
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.